- Home
- »
- Meetings
- »
- Industry/Academia Translational Oncology Symposium 2012
- »
- Understanding Rejection (How and Why) through the Melanoma Model
Understanding Rejection (How and Why) through the Melanoma Model
Francesco Marincola, MD, National Institutes of Health
Dr. Marincola is Chief of the Infectious Disease and Immunogenetics Section in the Department of Transfusion Medicine at the Clinical Center of the National Institutes of Heath in Bethesda, Maryland. He is also associate-Director of the Trans-NIH Center for Human Immunology and Director of the FOCIS Center for Excellence at NIH. Dr. Marincola received his MD, summa cum laude from the University of Milan, and his surgery training at Stanford University where he also completed a postdoctoral fellowship in surgical research. He joined the Surgical Oncology Branch of the National Cancer Institute, NIH, in 1990.
Dr. Marincola is a NIH tenured senior investigator, Adjunct Professor, Peking Union Medical College, Beijing, China, Adjunct Professor, First Military Medical University, Tonghe, Guangzhou – China, and President Elect of the Society for the Immunotherapy of cancer (Previously: International Society for Biological Therapy of Cancer) and President elect of the International Society for Translational Medicine. Dr. Marincola serves at the Editor-in-Chief, Journal of Translational Medicine; US Senior Editor of Immunotherapy, Associate Editor for The Journal of Immunotherapy, Tumori, and Clinical Cancer Research; Section Editor for Expert Opinion in Biological Therapy; Editorial Board, Cancer Immunology & Immunotherapy, The Journal of Experimental and Clinical Cancer Research.
Dr. Marincola is an author of over 450 peer reviewed research articles and over 100 abstracts. He has been invited to speak at over 200 national and international meetings. Dr. Marincola is the second most cited scientist in melanoma during the last ten years.
